World's Best Scientists 2026 revealed!
Paul J. Carter

Paul J. Carter

D-Index & Metrics

Biology and Biochemistry

D-Index
72
Citations
33595
World Ranking
6118
National Ranking
2873

Paul J. Carter publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Paul J. Carter sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 142 publications — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Paul J. Carter D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Paul J. Carter sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 72 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Paul J. Carter is affiliated with Genentech in the United States and has a research profile focused primarily on medicine and biochemistry, genetics, and molecular biology. Their work spans multiple subfields including radiology, nuclear medicine and imaging, molecular biology, oncology, immunology, and spectroscopy.

The scientist's main areas of study and research topics include monoclonal and polyclonal antibodies, protein purification and stability, CAR-T cell therapy, biosimilars and bioanalytical methods, glycosylation and glycoproteins, immune cell function and interaction, and T-cell and B-cell immunology.

Frequent coauthors in their research include Christoph Spiess, Patrick Wu, Andrew C. Chan, Gregory D. Martyn, and Saeed Izadi. These collaborations appear in various research outputs contributing to a breadth of topics within antibody therapeutics and immunology.

Paul J. Carter has published research in several scientific venues, with notable appearances in:

  • mAbs
  • Nature Reviews Immunology
  • Cell
  • Trends in Immunology
  • Nature Reviews Drug Discovery

Recent publications demonstrate their involvement in antibody-related research and immunogenicity assessments with selected papers including:

  • Designing antibodies as therapeutics, 2022, Cell
  • Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics, 2024, Nature Reviews Drug Discovery

Other publications relevant to antibody biophysics and safety assessment are:

  • Variable domain mutational analysis to probe the molecular mechanisms of high viscosity of an IgG 1 antibody, 2024, mAbs
  • Nonclinical immunogenicity risk assessment for knobs-into-holes bispecific IgG 1 antibodies, 2024, mAbs

Paul J. Carter's research contributions are situated at the intersection of antibody therapeutics and immune system interactions, with an emphasis on both biophysical properties and immunogenicity risk assessments. Their published work reflects ongoing investigations into improving the efficacy and safety profiles of antibody-based treatments.

Best Publications

  • Humanization of an anti-p185HER2 antibody for human cancer therapy.

    P. Carter;L. Presta;C. M. Gorman;J. B. B. Ridgway

  • Method for making humanized antibodies

    Paul J. Carter;Leonard G. Presta

  • Potent antibody therapeutics by design

    Paul J. Carter

  • Humanized antibodies and methods for making them

    Paul J. Carter;Leonard G. Presta

  • Hydrogen bonding and biological specificity analysed by protein engineering

    Alan R. Fersht;Jian-Ping Shi;Jack Knill-Jones;Denise M. Lowe

  • Improving the efficacy of antibody-based cancer therapies.

    Paul Carter

  • Therapeutic antibodies for autoimmunity and inflammation

    Andrew C. Chan;Paul J. Carter

  • Expression, in colon bacillus, of antibody fragment having at least cysteine present as free thiol, and use for production of bifunctional f(ab')2 antibody

    Paul J Carter;カーター,ポール・ジェイ

  • ‘Knobs-into-holes’ engineering of antibody CH3 domains for heavy chain heterodimerization

    John B.B. Ridgway;Leonard G. Presta;Paul Carter

  • Method for making multispecific antibodies having heteromultimeric and common components

    W. Robert Arathoon;Paul J. Carter;Anne M. Merchant;Leonard G. Presta

  • Dissecting the catalytic triad of a serine protease

    Paul Carter;James A. Wells

  • Improved oligonudeotide site-directed rautagenesis using M13 vectors

    Paul Carter;Hugues Bedouelle;Greg Winter

  • An efficient route to human bispecific IgG

    A. M. Merchant;Zhenping Zhu;Zhenping Zhu;J. Q. Yuan;A. Goddard

  • The use of double mutants to detect structural changes in the active site of the tyrosyl-tRNA synthetase (Bacillus stearothermophilus)

    Paul J. Carter;Greg Winter;Anthony J. Wilkinson;Alan R. Fersht

  • Next generation antibody drugs: pursuit of the 'high-hanging fruit'.

    Paul J. Carter;Greg A. Lazar

  • Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies.

    G D Lewis;I Figari;B Fendly;W L Wong

  • Alternative molecular formats and therapeutic applications for bispecific antibodies.

    Christoph Spiess;Qianting Zhai;Paul J. Carter

  • STERICALLY STABILIZED ANTI-HER2 IMMUNOLIPOSOMES : DESIGN AND TARGETING TO HUMAN BREAST CANCER CELLS IN VITRO

    Dmitri Kirpotin;John W. Park;Keelung Hong;Samuel Zalipsky

  • High level Escherichia coli expression and production of a bivalent humanized antibody fragment.

    Carter P;Kelley Rf;Rodrigues Ml;Snedecor B

  • Introduction to current and future protein therapeutics: A protein engineering perspective

    Paul J. Carter

Frequent Co-Authors

Greg Winter
Greg Winter University of Cambridge
Nan Chiang
Nan Chiang Brigham and Women's Hospital
Anthony J. Wilkinson
Anthony J. Wilkinson University of York
James A. Wells
James A. Wells University of California, San Francisco
Hans-Peter Gerber
Hans-Peter Gerber Seattle Genetics (United States)
Mary M.Y. Waye
Mary M.Y. Waye Chinese University of Hong Kong

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The fields of Biology and Biochemistry open doors to a variety of online degree programs and career opportunities in the life sciences and healthcare sectors. For those interested in the pharmaceutical field, online pharmd programs for non pharmacists offer a flexible route to an advanced pharmacy credential, even for students without a prior pharmacy background.

If human performance, rehabilitation, or physical wellness interests you, consider an exercise science degree online accredited to build expertise in movement, fitness, and sports science. Similarly, pursuing a kinesiology degree online can strengthen your qualifications for careers in physical therapy, athletic training, and health promotion.

For advancing skills in psychiatric and mental health nursing, the best online post master's pmhnp programs prepare nurses for specialized patient care roles. Whether you are just starting out or looking to specialize, these online programs provide flexibility and diverse pathways to rewarding jobs related to Biology and Biochemistry in the USA.

Best Scientists Citing Paul J. Carter

Trending Scientists

Recently Published Articles